2026-05-14T13:08:54-05:00 2025-06-30 390859910 BAKER TILLY ADVISORY GROUP LP 20 STANWIX STREET PITTSBURGH PA 15222 990 2024-07-01 251781357 NSABP FOUNDATION INC NSAB 4123395300 2 ALLEGHENY CENTER 1200 PITTSBURGH PA 15212 PEDRO BARELLI CFO 4123395300 2026-05-13 1 1 JEFFREY J SPENGLER P00109764 4126976400 2026-05-13 2024 2025-03-06 01:10:19Z PRIAYA RASTOGI 2 ALLEGHENY CENTER 1200 PITTSBURGH PA 15212 46127546 0 X WWW.NSABP.ORG X 1995 PA DESIGN AND CONDUCT CLINICAL STUDIES IN BREAST AND COLORECTAL CANCER TO IMPROVE TREATMENT AND ADVANCE THE STANDARD OF CARE. 7 5 83 6 0 0 4280581 4056920 30488650 36261667 1709998 2653624 1123278 1148874 37602507 44121085 15000 40000 0 0 7267366 7203169 0 0 0 26799826 30317279 34082192 37560448 3520315 6560637 112171594 121494372 41975533 38567642 70196061 82926730 DESIGN AND CONDUCT CLINICAL STUDIES IN BREAST AND COLORECTAL CANCER TO IMPROVE TREATMENT AND ADVANCE THE STANDARD OF CARE. 0 0 37107878 40000 36261667 THE USE OF CLINICAL TRIALS TO FURTHER THE UNDERSTANDING OF BREAST AND COLORECTAL CANCERS AND TO USE THIS INFORMATION TO REDUCE THE INCIDENCE OF THESE CANCERS. 37107878 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 26 0 83 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 5 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 PA X JULIE KARDELL SR DIRECTOR OF FINA 4123395319 2 ALLEGHENY CENTER SUITE 1200 PITTSBURGH PA 15212 X EVA BLUM DIRECTOR 1.00 0.00 X 0 0 0 HARRY BEAR MD PHD DIRECTOR 1.00 0.00 X 0 0 0 NORMAN WOLMARK MD CHAIR 10.00 4.00 X X 200003 0 0 PAT HALPIN-MURPHY MS DIRECTOR 1.00 0.00 X 0 0 0 PRIYA RASTOGI MD CHIEF EXECUTIVE OFFICER 39.00 1.00 X X 60000 0 0 SALLY MCCRADY DIRECTOR 1.00 0.00 X 0 0 0 SANDY SWAIN MD DIRECTOR 1.00 0.00 X 0 0 0 CARL NESBITT CHIEF FINANCIAL OFFICER (AS OF 4/30/2025) 40.00 1.00 X 0 0 0 CHARLES GEYER MD CHIEF SCIENTIFIC OFFICER 40.00 0.00 X 0 0 0 RONALD SUGAR ESQ CHIEF FINANCIAL OFFICER (UNTIL 4/30/25) 40.00 0.00 X 288876 0 35290 SHEILA EVANS DNP CHIEF OPERATING OFFICER 40.00 0.00 X 277531 0 11322 FRANCES FONZI DIRECTOR PROTOCOL DEVELOPM 40.00 0.00 X 131190 0 15133 HOPE ALCORN PROTOCOL NURSE 40.00 0.00 X 106454 0 10343 JULIE KARDELL SR. DIRECTOR OF FINANCE 40.00 0.00 X 155799 0 29188 KRISTEN KOTSKO DIRECTOR OF CLINICAL COORD 40.00 0.00 X 103796 0 27039 MARK BLOOM DIRECTOR OF CONTRACTS 40.00 0.00 X 156182 0 15272 PATRICIA SCHAEFER PROTOCOL NURSE 40.00 0.00 X 103979 0 28540 RANDY POLJAK DIRECTOR OF ACCOUNTING 40.00 0.00 X 123610 0 12793 REBECCA JOHNSON ASSOCIATE DIRECTOR OF SITE 39.00 0.00 X 107697 0 13404 STEVE NICHOLSON DIRECTOR OF FINANCIAL PLAN 40.00 0.00 X 120770 0 24965 SUDHEER KOMMAREDDY DIRECTOR OF DATA MANAGEMEN 40.00 0.00 X 112844 0 27956 THOMAS JULIAN ASSOC. DIR. OF MEDICAL AFF 16.00 1.00 X 114999 0 0 2163730 0 251245 16 0 1 0 ERMILI POTKA 24018 ENCLAVE DRIVE SOUTH LYON MI 48178 MONITORING 309795 KIMBERLY HAAS 4717 NEEDLE ROAD DECATUR IL 62626 MONITORING 303060 UNIVERSITY OF PITTSBURGH 3420 FORBES AVENUE PITTSBURGH PA 15260 CONSULTING 278675 LINDA ROBITAILLE 1109 SECOND AVENUE VERDUN CA H4G2W9 MONITORING 235280 RENEE RAKVICA 525 AUSTIN OAKS DRIVE GRAPEVINE TX 76051 MONITORING 197195 6 4008871 48049 4056920 RESEARCH PROGRAM FUNDING 541700 36261667 36261667 36261667 2708162 2708162 1951923 2001014 5447 -49091 -5447 -54538 -54538 SERVICE REIMBURSEMENT FROM NRG ON 900099 724149 724149 SERVICE REIMBURSEMENT FROM RTOG F 900099 320045 320045 OTHER REVENUE 900099 104680 104680 1148874 44121085 36261667 0 3802498 40000 40000 494811 321627 173184 5394821 3419556 1975265 861370 935610 -74240 452167 452167 94247 94247 65341 65341 168000 168000 3386578 2727521 659057 215255 133372 81883 846377 846377 675330 596791 78539 188805 188805 78441 274 78167 SITE PAYMENTS 14906239 14906239 0 SUBCONTRACTS 8433889 8433889 0 PURCHASED SERVICES 1115903 714256 401647 PROGRAM COSTS 142874 142874 0 4735869 -4735869 37560448 37107878 452570 0 15830654 16314159 13467553 11124887 185350 179341 13382880 11718738 789840 1664142 71786651 80184832 2771097 2574729 7340449 9452282 112171594 121494372 6801419 7888424 28755236 22717350 6418878 7961868 41975533 38567642 X 70046261 82746930 149800 179800 70196061 82926730 112171594 121494372 X 6560637 6198295 -28263 X 0 1 X 1 1 1 X 4227527 3678961 3932873 4280581 4056920 20176862 4227527 3678961 3932873 4280581 4056920 20176862 20176862 946335 2110469 2790241 2367127 2708162 10922334 873887 912734 959969 1123278 1148874 5018742 36117938 170400311 0.55860 0.57940 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: SERVICE REIMBURSMENT FROM NRG ONCOLOGY FOUNDATION INC - 2020 AMOUNT: $ 873,887. 2021 AMOUNT: $ 912,734. 2022 AMOUNT: $ 667,980. 2023 AMOUNT: $ 761,553. 2024 AMOUNT: $ 724,149. SERVICE REIMBURSMENT FROM RTOG FOUNDATION INC - 2022 AMOUNT: $ 215,830. 2023 AMOUNT: $ 321,874. 2024 AMOUNT: $ 320,045. OTHER REVENUE - 2022 AMOUNT: $ 76,159. 2023 AMOUNT: $ 39,851. 2024 AMOUNT: $ 104,680. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 89800 89800 89800 89800 89800 89800 29750 60050 89800 29750 29750 0.00000 1.00000 0.00000 0 0 1581898 1124297 457601 11338931 10594441 744490 462051 462051 1664142 457 ASSETS 342105 OPERATING LEASE RIGHT-OF-USE ASSETS 8109730 RECEIVABLE FROM NRG ONCOLOGY FOUNDATION, INC. 1000447 9452282 OPERATING LEASE LIABILITY 7961868 7961868 X 50123117 6198295 -196263 6002032 44121085 0 44121085 37392448 0 37392448 168000 168000 37560448 PART V, LINE 4: THE PURPOSE OF THE FUND IS TO PROVIDE FINANCIAL SUPPORT FOR EITHER OPERATING EXPENSES OR CAPITAL EXPENSES OF NSABP. PART X, LINE 2: THE FOUNDATION QUALIFIES AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR FEDERAL AND STATE INCOME TAX IS RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS. THE FOUNDATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES USING A RECOGNITION THRESHOLD OF MORE LIKELY THAN NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD IS MET. MANAGEMENT DETERMINED THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD IN 2025 AND 2024. THE FOUNDATION'S POLICY IS TO RECOGNIZE INTEREST AND PENALTY COSTS RELATING TO UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS, IF ANY, IN GENERAL AND ADMINISTRATIVE EXPENSES. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF INTEREST IN NET ASSETS OF NRG ONCOLOGY FOUNDATION, INC. -28,263. INVESTMENT MGT. FEES NETTED AGAINST REVENUE ON FINANCIALS -168,000. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MGT. FEES NETTED AGAINST REVENUE ON FINANCIALS 168,000. 0 PENNSYLVANIA BREAST CANCER COALITION 2397 QUENTIN RD STE B LEBANON PA 170429236 251722323 501(C)(3) 40000 0 GENERAL SUPPORT GENERAL SUPPORT 1 0 X X 0 0 0 0 0 0 0 0 0 RONALD SUGAR ESQ CHIEF FINANCIAL OFFICER (UNTIL 4/30/ 288876 0 0 0 0 0 12023 0 23267 0 324166 0 0 0 SHEILA EVANS DNP CHIEF OPERATING OFFICER 277531 0 0 0 0 0 9444 0 1878 0 288853 0 0 0 NORMAN WOLMARK MD CHAIR 200003 0 0 0 0 0 0 0 0 0 200003 0 0 0 JULIE KARDELL SR. DIRECTOR OF FINANCE 155799 0 0 0 0 0 6698 0 22490 0 184987 0 0 0 MARK BLOOM DIRECTOR OF CONTRACTS 156182 0 0 0 0 0 6381 0 8891 0 171454 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 LISA QUIGLEY AND JULIE KARDELL HAVE A FAMILY RELATION. FORM 990, PART VI, SECTION B, LINE 11B MANAGEMENT DETAIL REVIEWED DRAFT COPY OF 990 WITH THE FINAL COPY PROVIDED TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C ON AN ANNUAL BASIS, CONFLICT OF INTEREST DISCLOSURES ARE SENT TO ALL APPLICABLE BOARD MEMBERS, SENIOR MANAGEMENT, AND KEY EMPLOYEES IN WHICH SAID PERSONS PROACTIVELY DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF SENIOR MANAGEMENT IS REVIEWED BY AN INDEPENDENT OUTSIDE CONSULTANT AND RECOMMENDATIONS FORMULATED BY A COMPENSATION SUBCOMMITTEE ARE PRESENTED TO THE CHAIRMAN FOR APPROVAL. A REPORT OF THE PROCESS AND CHAIRMAN'S DECISION IS MADE TO THE FULL BOARD OF DIRECTORS. COMPENSATION OF EMPLOYEES IS REVIEWED BY SENIOR MANAGEMENT ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A: THE FOUNDATION PAYS TO THE UNIVERSITY OF PITTSBURGH FOR THE CONSULTANCY SERVICES RENDERED BY THE FOLLOWING INDIVIDUALS LISTED ON PART VII, SECTION A: - CHARLES GEYER, MD (CHIEF SCIENTIFIC OFFICER) WITH CALENDAR YEAR COMPENSATION OF $278,675 FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF INTEREST IN NET ASSETS OF NRG ONCOLOGY FOUNDATION, INC. -28,263. NRG ONCOLOGY FOUNDATION INC 1600 JFK BOULEVARD SUITE 1020 PHILADELPHIA PA 19103 900912747 ONCOLOGY RESEARCH SUPPORT PA 501(C)(3) LINE 7 N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0